Table 3.

Main effects and interaction effects of the fitted mixed model; narcolepsy type 1 patients using both modafinil and sodium oxybate excluded

Parameter	Estimate (95% CI)	F‐ and p‐values
Gender	Female: −0.751 (−1.56; 0.05)	F(1,72.923) = 3.464, p = .067
Study drug	SXB: −1.198 (−2.03; −0.36)	F(1,69.396) = 8.180, p = .006
Baseline BMI	−0.017 (−0.10; 0.06)	F(1,71.713) = 0.177, p = .675
Follow‐up (years)	−0.154 (−0.54; 0.23)	F(1,40.695) = 0.690, p = .411
Gender*follow‐up	Female: −0.333 (−0.96; 0.30)	F(1,27.231) = 1.178, p = .287
Study drug*follow‐up	SXB: −0.911 (−1.62; −0.20)	F(1,34.531) = 6.784, p = .013
Baseline BMI*follow‐up	−0.067 (−0.13; −0.01)	F(1,26.040) = 5.137, p = .032

BMI, body mass index.